Search

everythinglearnresearchcommunity

for

Search:↓

Putting calcipotriol ointment on the skin once doesn't change calcium levels in the body right away.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Tofacitinib helped a woman regrow hair with no major side effects.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Dupilumab helped a 13-year-old regrow hair after alopecia totalis.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Lupus pneumonitis can mimic tuberculosis and should be considered in diagnoses.

Twice-weekly 5 mg betamethasone helps hair regrowth in alopecia areata.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Brodalumab is more effective than ustekinumab for treating psoriasis.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.